Boehringer Ingelheim sets up its first Asian Veterinary R&D-Center in Shanghai

(12.03.2012) The research based pharmaceutical company accelerates the expansion of its Animal Health business in China

Boehringer Ingelheim today announced the expansion of its Animal Health business in China. One of the major moves is the opening of the Asian Veterinary Research & Development (R&D) Center in Zhangjiang, Shanghai.

Boehringer Ingelheim Boehringer Ingelheim invests 12 million euros in the center which is the largest of its kind established by a multinational pharmaceutical company in China. With the investment, the company creates 70 new scientific workplaces.

“Boehringer Ingelheim’s long term focus is to further strengthen its very strong global position in the Animal Health business, particularly in the vaccine segment. In line with our corporate vision ‘Value through Innovation’ we research, develop and manufacture innovative products addressing our customer’s needs, be it in the companion animal as well as the food animal segment”, said Hubertus von Baumbach, responsible for the Corporate Board Divisions Finance and Animal Health.

“We strongly believe that with our research driven product development we can add value to the Chinese market and to the businesses of our local customers. Investing in one of our core competencies here in China underlines our commitment”.

With the emergence of new pathogens, it is important to establish a local research presence to shorten development times and to provide solutions to customers in China faster. The Asian Veterinary R&D Center will develop innovative vaccines against swine and poultry diseases that may threaten China’s farming husbandry in the future.

“As a part of Boehringer Ingelheim’s international R&D organisation, the Asian Veterinary R&D Center is positioned to identify and develop innovative vaccines against livestock diseases focusing on China and Asian markets”, stated Marcus Conradt, Head of the Asian Veterinary R&D Center. “The center will be supported by our research facilities around the world, and be a supporting member itself in our global R&D network.”

The center, covering 1,900 square meters, is located within the Shanghai Zhangjiang High-Tech Park. Scientists of this state-of-the-art facility will carry out all aspects of modern vaccine development. Furthermore, the research center will also provide new jobs for local scientists and bring new bio-research technologies to the country.

Mai multe Ştiri

Michael Lappin; Bildquelle: WSAVA

Free WSAVA Webinar: The Impact of COVID-19 on your Patients and Staff - An Update for Veterinary Professionals

The World Small Animal Veterinary Association (WSAVA) is to host a second free webinar for veterinarians globally on Tuesday September 15 to provide an update on COVID-19 as it relates to companion animals and address many frequently asked questions
Citește mai mult

FEDIAF lansează un ghid electronic de training dedicat comunicării cu privire la hrana animalelor de companie

FEDIAF lansează un ghid electronic de training dedicat comunicării cu privire la hrana animalelor de companie

FEDIAF (Federaţia Europeană a Industriei de Petfood) a lansat un ghid electronic de training pentru o mai bună cunoaştere şi punere în aplicare a legislaţiei privind hrana animalelor de companie şi normelor voluntare privind comunicarea „on-pack” şi „off-pack
Citește mai mult

Dr. Luba Gancheva; Bildquelle: WSAVA

Luba Gancheva este câștigătorul premiului veterinar WSAVA, "Next Generation" al companiei Hill, 2017

Judecătorii felicită angajamentul față de creșterea standardelor de îngrijire veterinară în Balcani
Citește mai mult


Bayer vrea sa cumpere Monsanto cu 55 miliarde de euro. O propunere imorala?

Concernul german Bayer intentioneaza sa cumpere firma americana Monsanto, mare si controversat producator de erbicide si porumb modificat genetic. Oferta Bayer AG aparuta pe DAX este de 62 miliarde dolari (55 miliarde euro). Aceasta exprima un pret de 122 USD pe actiunea la bursa a Monsanto, cu 37% mai mare decat pretul de inchidere de acum doua saptamani.
Citește mai mult

European Wildlife Disease Association (EWDA)

12th Conference of the European Wildlife Disease Association (EWDA)

August 27-31, 2016, Berlin - Online registration and Abstract submission now open
Citește mai mult

Federation of Veterinarians of Europe (FVE)

Animal Health Law: FVE welcomes its adoption

The Federation of Veterinarians of Europe (FVE) welcomes the adoption of the EU Law on transmissible animal diseases, also called the Animal Health Law (AHL)
Citește mai mult


Federaţia Veterinarilor din Europa se opune reclasificării Ketaminei

Am dori să subliniem susținerea nostru pentru Rapoartele Critice de evaluare ale Comisiei dvs. şi Recenziile experţilor, care afirmă că nu există dovezi care să justifice controlul internaţional al Ketaminei.
Citește mai mult


Frédéric Goulle și Yvonne van Zeeland câștigă premiile FECAVA 2015

Premiile au fost prezentate în 16 Octobrie la Eurocongresul SEVC/FECAVA din Barcelona de către Președintele Fecava Monique Megens și editorul EJCAP Karin de Lange.
Citește mai mult